GP may also have a positive effect on lipid metabolites by inhibiting the activity of lipogenic and cholesterol-genic enzymes, such as malic enzyme, fatty acid synthases, and glucose-6-phosphatase dehydrogenase, resulting in hypocholesterolemia and hypolipidemic action [51]. Here, FASN is linked to Hypocholesterolemia.